Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neoplasms × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Interventional 264 Observational 52 Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 16 CNS 6 Sarcoma 4 Lymphoid 4 Other hematologic neoplasm 2 Gynecologic 2 Gastrointestinal 2 Endocrine 2 Breast 2 Thoracic 1 Other neoplasm 1 NET 1 Myeloid 1 Genitourinary 1 Dermatologic 1 Classical hematology 1

Conditions

Melanoma 20 Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Carcinoma, Basal Cell 3 Uveal Melanoma 2 Prostatic Neoplasms 2 Lymphoma, T-Cell, Cutaneous 2 Glioma 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Liver Neoplasms 1 Keratosis 1 Hodgkin Disease 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory 1 Cholangiocarcinoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04853602 2024-08-12

IFx-Hu2.0 Expanded Access Program

TuHURA Biosciences, Inc.

Melanoma, Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡